Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

214 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Computer-assisted chromatin texture characterization of Feulgen-stained nuclei in a series of 331 transitional bladder cell carcinomas.
van Velthoven R, Petein M, Zlotta A, Oosterlinck WJ, van der Meijden A, Zandona C, Roels H, Pasteels JL, Schulman C, Kiss R. van Velthoven R, et al. J Pathol. 1994 Jul;173(3):235-42. doi: 10.1002/path.1711730306. J Pathol. 1994. PMID: 7523643
Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
van Velthoven R, Petein M, Oosterlinck WJ, Zandona C, Zlotta A, Van der Meijden AP, Pasteels JL, Roels H, Schulman C, Kiss R. van Velthoven R, et al. Hum Pathol. 1995 Jan;26(1):3-11. doi: 10.1016/0046-8177(95)90108-6. Hum Pathol. 1995. PMID: 7821913
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI. Shariat SF, et al. J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669. J Clin Oncol. 2008. PMID: 18349404
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
Gupta A, Karakiewicz PI, Roehrborn CG, Lotan Y, Zlotta AR, Shariat SF. Gupta A, et al. Clin Cancer Res. 2008 Nov 15;14(22):7385-90. doi: 10.1158/1078-0432.CCR-07-5110. Clin Cancer Res. 2008. PMID: 19010854
Lymphadenectomy in the surgical management of penile cancer.
Protzel C, Alcaraz A, Horenblas S, Pizzocaro G, Zlotta A, Hakenberg OW. Protzel C, et al. Eur Urol. 2009 May;55(5):1075-88. doi: 10.1016/j.eururo.2009.02.021. Epub 2009 Feb 23. Eur Urol. 2009. PMID: 19264390 Review.
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.
van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR. van Rhijn BW, et al. Eur Urol. 2009 Sep;56(3):430-42. doi: 10.1016/j.eururo.2009.06.028. Epub 2009 Jun 26. Eur Urol. 2009. PMID: 19576682 Review.
An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.
Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A, Zlotta A. Kulkarni GS, et al. Eur Urol. 2010 Jan;57(1):60-70. doi: 10.1016/j.eururo.2009.08.024. Epub 2009 Sep 1. Eur Urol. 2010. PMID: 19740595 Review.
The management of BCG failure in non-muscle-invasive bladder cancer: an update.
Zlotta AR, Fleshner NE, Jewett MA. Zlotta AR, et al. Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S199-205. doi: 10.5489/cuaj.1196. Can Urol Assoc J. 2009. PMID: 20019985 Free PMC article.
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer.
Zlotta AR, Cohen SM, Dinney C, Droller M, van der Kwast TH, van Rhijn BW, Bochner B, Ameil G, Jewett MA. Zlotta AR, et al. Urol Oncol. 2010 May-Jun;28(3):329-33. doi: 10.1016/j.urolonc.2009.10.011. Urol Oncol. 2010. PMID: 20439032
214 results
Jump to page
Feedback